1.
Bozdogan A, Emiroglu S, Abuaisha A, Basar OD. Risk Factors of Response to Neoadjuvant Chemotherapy in Patients with Luminal (HER2 Negative) Breast Cancer: Roc Curve and Logistic Regression Model Results: RF of response to NAC in HER2- BC. Arch Breast Cancer [Internet]. 2024 Jan. 31 [cited 2024 Nov. 21];11(1):67-74. Available from: https://archbreastcancer.com/index.php/abc/article/view/841